Clinical Trials Logo

Clinical Trial Summary

The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in healthy subjects

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

  • Pharmacokinetics in Healthy Adults

NCT number NCT05032833
Study type Interventional
Source Beckley Psytech Limited
Contact Research Assistant
Phone 0203 299 1851/1852
Email [email protected]
Status Recruiting
Phase Phase 1
Start date September 2021
Completion date March 2022

See also
  Status Clinical Trial Phase
Completed NCT02561442 - Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration Phase 2/Phase 3